Cogent Biosciences (COGT) Current Leases (2019 - 2021)
Historic Current Leases for Cogent Biosciences (COGT) over the last 3 years, with Q3 2021 value amounting to $2.3 million.
- Cogent Biosciences' Current Leases rose 1333.0% to $2.3 million in Q3 2021 from the same period last year, while for Sep 2021 it was $2.3 million, marking a year-over-year increase of 1333.0%. This contributed to the annual value of $2.1 million for FY2020, which is 2674.49% up from last year.
- According to the latest figures from Q3 2021, Cogent Biosciences' Current Leases is $2.3 million, which was up 1333.0% from $2.2 million recorded in Q2 2021.
- Cogent Biosciences' Current Leases' 5-year high stood at $2.3 million during Q3 2021, with a 5-year trough of $1.5 million in Q1 2019.
- For the 3-year period, Cogent Biosciences' Current Leases averaged around $1.8 million, with its median value being $1.7 million (2020).
- As far as peak fluctuations go, Cogent Biosciences' Current Leases surged by 1001.99% in 2020, and later soared by 2862.19% in 2021.
- Quarter analysis of 3 years shows Cogent Biosciences' Current Leases stood at $1.6 million in 2019, then rose by 26.74% to $2.1 million in 2020, then rose by 9.8% to $2.3 million in 2021.
- Its Current Leases stands at $2.3 million for Q3 2021, versus $2.2 million for Q2 2021 and $2.1 million for Q1 2021.